E11
Conditions
Interventions
Group 1: Control group: the patients are randomly assigned to the control group for usual care
Group 2: Intervention group: the patients are randomly assigned to the intervention group. They receive
Sponsors
EvivaMed Distribution GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Type 2 Diabetes mellitus: HbA1c = 7,5 % and < 10,0 %
Exclusion criteria
Exclusion criteria: Other Diabetes mellitus entity, life-shortening comorbidities, after organ transplants, pregnancy, cared for or incarcerated patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes between Baseline and 26 weeks (individually and collectively) in the medical parameter HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| health-related quality of life(SF-12), Diabetes treatment satisfaction questionnaire (DTSQ), problem areas in Diabetes (PAID), medical parameters: blood pressure and weight, degree of achievement of individual therapy goals | — |
Countries
Germany
Contacts
Public ContactMarlo Verket
KKS der Medizinischen Klinik I, Uniklinik RWTH Aachen
Outcome results
None listed